Joslin Leadership

Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education, Joslin's Boards of Trustees and Overseers work in tandem with the executive team. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge—a hallmark of this one-of-a-kind Center.

Publicly representing the institution, Joslin's Board comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of conquering diabetes in all of its forms.

Board of Trustees

W. Ray Allen, Wellesley, MA

Peter S. Amenta, M.D., Ph.D., University of Medicine and Dentistry of NJ, Robert Wood Johnson Medical School, New Brunswick, NJ

John J. Cook, Jr., Managing Director, Seaward Management Corp., Boston, MA

Nathaniel S. Gardiner, Edwards Angell Palmer & Dodge, Boston, MA

Morella M. Grossmann, Caracas, Venezuela

Ralph M. James, Chairperson of the Board, Executive Director, Executive Education, Harvard Business School, Boston, MA

Ann M. Lagasse, Newburyport Development, Newburyport, MA

W. Alan McCollough, Atlanta, GA

James L. Peterson, Chardonne, Switzerland

Geoffrey S. Rehnert, Founder and Co-CEO, Audax Management Co. LLC, Boston, Mass.

Richard A. Smith, Chestnut Hill, MA

Ex Officio

John L. Brooks III, President and CEO, Joslin Diabetes Center, Boston, MA

Martin J. Abrahamson, M.D., Senior Vice President and Chief Medical Officer, Joslin Diabetes Center, Boston, MA

George L. King, M.D., Senior Vice President and Chief Scientific Officer, Joslin Diabetes Center, Boston, MA

Honorary Trustees

George F. Cahill, Jr., M.D., Stoddard, NH

Charles H. Hood, Brookline, MA

Patrick H. O’Neill, New Canaan, CT

Kenneth E. Quickel, M.D., Centerville, MA